Fresh Rounds

BiomeSense, Inc. funding

BiomeSense, Inc., a biotechnology company based in Chicago, IL, filed a Form D with the SEC on November 3, 2025 and reported $7.1M raised of a $7.3M offering.

Amount raised$7.1M
Offering size$7.3M
Filed with the SECNovember 3, 2025
First saleJuly 18, 2025
IndustryBiotechnology
SecuritiesOptions or warrants
LocationChicago, IL
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far27
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Illinois